Hepatitis C, Acute Recruiting Phase 2 Trials for Sofosbuvir (DB08934)

Also known as: Acute Hepatitis C / Acute hepatitis C NOS

IndicationStatusPhase
DBCOND0076207 (Hepatitis C, Acute)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03818308Trial for the Treatment of Acute Hepatitis C for 8 Weeks With Sofosbuvir/VelpatasvirTreatment